OncoMed, Celgene To Jointly Advance Multiple Anti-Cancer Stem Cell … – NASDAQ
|
OncoMed, Celgene To Jointly Advance Multiple Anti-Cancer Stem Cell …
NASDAQ (RTTNews.com) – OncoMed Pharmaceuticals, Inc. ( OMED ) and Celgene Corp. ( CELG ) announced an agreement to jointly develop and commercialize up to six anti-cancer stem cell or CSC product candidates from OncoMed’s biologics pipeline, including … Celgene commits $3.3B in whopper cancer stem cell deal with OncoMedFierceBiotech OncoMed and Celgene Announce Strategic Collaboration Advancing Multiple …GlobeNewswire (press release) OncoMed and Celgene to jointly develop six cancer drugsReuters India Wall Street Journal all 10 news articles |
